<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002488'>Acute leukemias</z:hpo> containing &gt; 3% myeloperoxidase (MPO)-positive blast cells, as detected cytochemically, are considered to be myelogenous in origin, regardless of the immunophenotypic markers expressed </plain></SENT>
<SENT sid="1" pm="."><plain>Conversely, <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> that express only myeloid antigens are also considered to be <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), even in the absence of MPO </plain></SENT>
<SENT sid="2" pm="."><plain>These MPO-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMLs</z:e>, designated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M0 in the FAB classification, currently require either immunophenotypic or electron microscopic studies for identification </plain></SENT>
<SENT sid="3" pm="."><plain>To examine the association of MPO and myeloid antigen expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, particularly at the early stages of myeloid cell differentiation, we have used in situ hybridization (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) to evaluate MPO gene expression in myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines and a variety of well-characterized <z:hpo ids='HP_0002488'>acute leukemias</z:hpo>, including six cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M0 </plain></SENT>
<SENT sid="4" pm="."><plain>Strong positivity for MPO <z:chebi fb="2" ids="33699">mRNA</z:chebi> was detected in the myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell line <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 and in 22 of 27 AMLs (three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M0, four <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M1, eight <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M2, five <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M4, two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M5a) </plain></SENT>
<SENT sid="5" pm="."><plain>No MPO gene expression was detected in three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M0, one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M5a, one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M7, 5 <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, the lymphoid cell lines Molt-4 and Namalwa, or in the early myeloid cell lines KG-1 and KG-1a </plain></SENT>
<SENT sid="6" pm="."><plain>Ultrastructural studies for MPO activity were performed on four <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M0; one <z:hpo ids='HP_0001909'>leukemia</z:hpo> showed both gene expression and cytochemical activity, whereas two others contained neither MPO transcripts nor enzyme </plain></SENT>
<SENT sid="7" pm="."><plain>Weak MPO gene expression was evident in one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M0 that was negative for enzymatic activity by electron microscopy </plain></SENT>
<SENT sid="8" pm="."><plain>These studies show MPO gene expression can be detected by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> in about half of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M0, supporting their presumed myelocytic derivation.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>